DF
MRK icon

DNCA Finance’s Merck MRK Stock Holding History

DNCA Finance’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-118,896
Closed -$14.7M – 129
2024
Q2 		$14.7M Buy
+118,896
New +$15.3M 1.26% 21

Other funds holding MRK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

DNCA Finance's MRK Position: Q3 2024 in Review

DNCA Finance sold out of Merck (MRK) in Q3 2024, closing a stake of 118,896 shares — an estimated $14.7M sold.

DNCA Finance first reported a position in MRK in Q2 2024 and held it in 1 quarter. The position peaked at $14.7M in Q2 2024. 3,489 funds tracked by Wall St. Rank hold MRK as of Q3 2024.

  • DNCA Finance reported no remaining Merck position as of Q3 2024 after selling out during the quarter.
  • DNCA Finance sold 118,896 Merck shares in Q3 2024, an estimated $14.7M.
  • DNCA Finance first reported a position in Merck in Q2 2024 and held it in 1 quarter.
  • DNCA Finance's Merck position peaked at $14.7M in Q2 2024.
  • 3,489 funds tracked by Wall St. Rank held Merck as of Q3 2024.

Based on DNCA Finance's 13F filing for Q3 2024, filed 13 Nov 2024.